High concentrations of the CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid between patients with and without endometriosis

Objective In the present study we compared the levels of CA-125, CA 19-9, and CA 15-3 in the peritoneal fluid (PF) of patients with and without endometriosis, then assessed the possibility of a correlation among these tumor markers. Study design Our study was a controlled clinical study of patients undergoing laparoscopy for infertility or other benign gynecology conditions. Peritoneal fluid samples were collected from 65 women with endometriosis and 43 women without pelvic disease. Levels of CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid were determined by immunoradiometric assay.

The concentration of CA-125 in PF from patients with endometriosis was significantly higher than that in the control group (p<0.001); for CA 19-9 and CA 15-3, PF concentrations were not statistically different between these two groups. Women with endometriosis had significantly higher levels of CA-125 in proliferative and secretory phases than the control group (p<0.001 and p<0.002 respectively); furthermore, in patients with endometriosis the CA 19-9 levels were significantly lower in secretory phase than the proliferative (p<0.004). The levels of CA-125 were significantly lower in women with tubal ligation, in comparison with infertility or pelvic pain in the control group (p<0.001). No significant difference was seen in women with infertility or pelvic pain in endometriosis group and the levels of CA-125, CA 19-9, and CA 15-3. We did not find any correlation between the stages of endometriosis and the concentration of CA-125, CA 19-9 and CA 15-3. A significant correlation between the CA 19-9 levels and CA 15-3 in patients with endometriosis was found (r=0.72, p=0.001).

We found high concentrations of CA-125, CA 19-9, and CA 15-3 in the peritoneal fluid of women with and without endometriosis in the Yale series. However, the levels only of CA-125 were higher in women with endometriosis, but without diagnostic value. The role of simultaneously high concentrations of CA 19-9 and CA 15-3 in women with endometriosis needs to be explored further. Similar content being viewed by others

American Fertility Society (1985) Revised American Fertility Society classification of endometriosis. Fertil Steril 43:351–352 Arici A, Oral E, Attar E, Tazuke SI, Olive DL (1997) Monocyte chemotactic protein-1 concentration in peritoneal fluid in patients with endometriosis and its modulation in human mesothelial cells. Fertil Steril 67:1065–1072 Barbati A, Cosmi EV, Spaziani R, Ventura R, Montanino G (1994) Serum and peritoneal fluid CA-125 levels in patients with endometriosis. Fertil Steril 61:438–442 Barbieri RL, Niloff JM, Bast RC, Schaetzl E, Kistner RW, Knapp RC (1986) Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril 45:630–634 Bast RC, Klug TL, John E, Jenison E, Niloff JM, Lazarus H et al (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 300:883–889 Bon GG, Kenemans P, Dekker JJ, Hompes PG, Verstraeten RA, Kamp G-J et al (1999) Fluctuations in CA-125 and CA 15-3 serum concentrations during spontaneous ovulatory cycles. Hum Reprod 14:566–570 Fedele L, Vercellini P, Arcaini L, da Dult MG, Candiani GB (1988) CA-125 in serum, peritoneal fluid, active lesions, and endometrium with patients with endometriosis. Am J Obstet Gynecol 158:166–170 Fisk NM, Tan CE (1988) CA-125 in peritoneal fluid and serum of patients with endometriosis. Eur J Obstet Gynecol Reprod Biol 29:153–158 Gürgan T, Kishisci H, Yarali H, Aksu T, Zeyneloglu H, Develioglu O (1990) Serum and peritoneal fluid CA-125 levels in early stage endometriosis. Gynecol Obstet Invest 30:105–108 Kabawat SE, Bast RC, Bhan AK, Welch WR, Knapp RC, Colvin RB (1983) Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC 125. Int J Gynecol Pathol 2:275–285 Magnani LJ, Steplewski Z, Koprowski H, Ginsburg V (1983) Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res 43:5489–5497 Matalliotakis I, Makrigiannakis A, Karkavitsas N, Psaroudakis E, Froudarakis G, Koumantakis E (1994) Use of CA-125 in the diagnosis of endometriosis: influence of treatment with danazol. Int J Fertil 39:100–104 Matalliotakis I, Panidis D, Vlassis G, Neonaki M, Goumenou A, Koumantakis E (1998) Unexpected increase of the CA 19-9 tumour marker in patients with endometriosis. Eur J Gynecol Oncol 5:490–493 Moen MH, Hagen B, Onsrud M (1991) CA-125 in peritoneal fluid from patients with endometriosis. Hum Reprod 6:1400–1403 Mol BW, Bayran N, Lijmer JG, Wiegerinck MA, Bongers MY, Veen F, Bossuyt PM (1998) The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 70:1101–1108 Moretuzzo RW, Chen SL, DiLauro S, Reindollar RH, Jension E, McDonough PG (1988) Serum and peritoneal lavage fluid CA-125 levels in endometriosis. Fertil Steril 50:430–433 Olt G, Berchuck A, Bast R Jr (1990) The role of tumor markers in gynecologic oncology. Obstet Gynecol Surv 45:570–577 Panidis D, Vlassis G, Matalliotakis J, Skiadopoulos S, Kalogeropoulos A (1999) Serum levels of the oncofetal antigens CA-125, CA 19-9 and CA 15-3 in patients with endometriosis. J Endocrinol Invest 11:801–804 Pittaway DE, Fayez JA (1986) The use of CA-125 in the diagnosis and management of endometriosis. Fertil Steril 46:790–795 Suzuki M, Sekiguchi I, Tamada I (1990) Clinical evaluation of tumor-associated mucin-type glycoprotein CA 54/61 in ovarian cancers: comparison with CA-125. Obstet Gynecol 76:422–427 Williams RS, Rao CV, Yussman MA (1988) Interference in the measurement of CA-125 in peritoneal fluid. Fertil Steril 49:547–550 Acknowledgments The authors are grateful to Dr Arici, Professor and Director of Division of Reproductive Endocrinology and Infertility, at Yale University School of Medicine, New Haven, Connecticut, USA for their important contributions to this manuscript and especially for participation in the collection of peritoneal fluid samples. We thank Dr Mahutte for medical support. We thank the staff of the Department of Nuclear Medicine, University of Crete, Greece, for their technical assistance. This work was generously supported by a grant from the Department of Gynaecology and Obstetrics, University of Crete. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Matalliotakis, I.M., Goumenou, A.G., Mulayim, N. et al. High concentrations of the CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid between patients with and without endometriosis. Arch Gynecol Obstet 271, 40–45 (2005). https://doi.org/10.1007/s00404-004-0645-7 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00404-004-0645-7